Mr. Dhirendra V. Singh, the Managing Director of Genelife Clinical Research, is a visionary leader with a passion for advancing healthcare through cutting-edge clinical research and innovation. With a distinguished background in the pharmaceutical and clinical research industries, Mr. Singh brings a wealth of expertise to his role at Genelife. As Managing Director, Mr. Singh is the driving force behind the company’s mission to provide cost-effective Phase I-IV clinical research services and accelerate the drug development process. His leadership is characterized by a commitment to excellence, transparency, and a patient-centric approach. Under Mr. Singh’s guidance, Genelife Clinical Research has expanded its global presence, establishing a strong foothold in key regions, including India, Europe, the USA, and the UK. As a leader in the field, Dhirendra V. Singh is instrumental in shaping Genelife Clinical Research into a trusted partner for pharmaceutical, medical device, and biologics companies seeking to drive innovation and make a positive impact on healthcare worldwide. His leadership inspires the Genelife team to continually push the boundaries of what is possible in clinical research, ultimately benefiting patients and advancing the frontiers of medicine.
Dr.Sherifuddin Sheriff is a Medical Doctor. He has more than sixteen years of experience as clinical research consultant, independent monitor and expert consultant for Pharma companies and CROs. As an independent consultant/ auditor he has conducted several audits and inspections. He has audited/monitored studies for various regulatory bodies including USFDA, AFFSAPS, MHRA, EMEA, Health CANADA etc. He started his career as Principle investigator and Deputy Manager in BA/BE studies. He also has experience of monitoring early phase clinical trials (phase I and II oncology trials). He has worked as at senior level in various organizations. Before starting his career as Independent consultant he was head of Actimus Bio.
Mrs. Himali Chaturvedi, significant role and expertise in the field of quality assurance, especially within the context of Genelife Clinical Research. Her background in new drug development, quality control, molecular biology, animal pharmacology, and toxicology, combined with her experience in developing quality control standards, is valuable for maintaining the highest standards of quality in clinical, pre-clinical organizations, and R&D labs. Her 13 tenure as the head of the Quality Assurance Department at Genelife Clinical Research highlights her commitment to ensuring the quality and safety of clinical research operations. Quality assurance is an essential aspect of clinical trials and research, ensuring that processes and outcomes meet rigorous standards and compliance with regulatory requirements. This expertise and experience in quality assurance play a crucial role in ensuring that Genelife Clinical Research continues to deliver exceptional services in clinical trials and research, which ultimately benefits patients, the medical community, and the pharmaceutical industry. Mrs. Himali Chaturvedi’s contributions in this role are instrumental in the success and reputation of Genelife Clinical Research.